Abstract
At the level of the cell, cancer is essentially a genetic disease. Studies from multiple disciplines, including molecular biology, somatic cell genetics, genetic epidemiology, tumor virology, chemical carcinogenesis, and others, have converged over the last few decades to provide many fundamental insights into the genetic basis of cancer. These studies have shown that the genesis of malignant tumors is dependent on the accumulation of a series of DNA alterations that generally occur somatically, but can also be inherited in the germ line. These alterations have a cumulative effect on many important cellular processes that become dysfunctional in cancers, including growth control, differentiation, and interactions of the affected cell with its microenvironment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aaltonen L, Peltomaki P, Leach F, Sistonen P, Pylkkanen L, Mecklin J, Jarvinen H, Powell S, Jen J, Hamilton S, Petersen G, Kinzler K, Vogelstein B, de la Chapelle A (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260: 812–816
Adams RL, Lindsay H (1993) What is hemimethylated DNA? FEBS Lett 320: 243–245
Antequera F, Boyes J, Bird A (1990) High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62: 503–514
Baker W, Hatch KD, Shingleton HM (1988) Amplification of the c-myc proto-oncogene in cervical carcinoma. J Surg Oncol 39: 225–228
Barbacid M (1987) Ras genes. Annu Rev Biochem 56: 779–827
Bartram CR, De Klein A, Hagemeijer A, van Agthoven T, Geurts van Kessel A, Bootsma D, Grosveld G, Ferguson-Smith MA, Davies T, Stone M et al (1983) Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature 306: 277–280
Bestor T, Laudano A, Mattaliano R, Ingram V (1988) Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol 203: 971–983
Bishop JM (1985) Viral oncogenes. Cell 52: 301–354
Blackwood EM, Eisenman RN (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251: 1211–1217
Boguski MS, McCormick F (1993) Proteins regulating Ras and its relatives. Nature 366: 643–654
Borden EC, Waalen J, Liberati AM, Grignani F (1993) Molecular diagnosis and monitoring of leukemia and lymphoma. Leuk Res 17: 1073–1078
Bos JL (1989) ras oncogenes in human cancer: a review. Cancer Res 49: 4682–4689
Bourne HR, Sanders DA, McCormick F (1990) The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348: 125–132
Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88: 10124–10128
Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN, Sidransky D (1995) Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332: 429–435
Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121–1124
Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A, Tannergard P, Bollag RJ, Godwin AR, Ward DC, Nordenskjold M, Fishel R, Kolodner R, Liskay RM (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368: 258–260
Burks RT, Kessis TD, Cho KR, Hedrick L (1994) Microsatellite instability in endometrial carcinoma. Oncogene 9: 1163–1166
Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE (1994) Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 54: 3568–3573
Capon DJ, Chen EY, Levinson AD, Seeburg PH, Goeddel DV (1983) Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature 302: 33–37
Cho YJ, Gonna S, Jeffrey PD, Pavletich NP (1994) Crystal structure of a p53 tumor suppressor DNA complex — understanding tumorigenic mutations. Science 265: 346–355
Cleary ML, Smith SD, Sklar J (1986) Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47: 19–28
Collins S, Groudine M (1982) Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature 298: 679–681
Collins SJ, Kubonishi I, Miyoshi I, Groudine MT (1984) Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells. Science 225: 72–74
Cox EC (1976) Bacterial mutator genes and the control of spontaneous mutation. Annu Rev Genet 10: 135–156
Dalla-Favera R, Wong-Staal F, Gallo RC (1982) Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient. Nature 299: 61–63
de Bustros A, Nelkin BD, Silverman A, Ehrlich G, Poiesz B, Baylin SB (1988) The short arm of chromosome 11 is a “hot spot” for hypermethylation in human neoplasia. Proc Natl Acad Sci USA 85: 5693–5697
De Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagmeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR (1982) A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300: 765–767
De Klein A, Hagemeijer A, Bartram CR, Houwen R, Hoefsloot L, Carbonell F, Chan L, Barnett M, Greaves M, Kleihauer E et al (1986) bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. Blood 68: 1369–1375
DePinho RA, Schreiber-Agus N, Alt FW (1991) myc family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res 57: 1–46
Der CJ, Krontiris TG, Cooper GM (1982) Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci USA 79: 3637–3640
Dougall WC, Qian X, Peterson NC, Miller MJ, Samanta A, Greene MI (1994) The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene 9: 2109–2123
Dowell SP, Hall PA (1994) The clinical relevance of the p53 tumour suppressor gene. Cytopathology 5: 133–145
Drebin JA, Link VC, Greene MI (1988) Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo. Oncogene 2: 387–394
Dryja TP, Rapaport JM, Joyce JM, Petersen RA (1986) Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas. Proc Natl Acad Sci USA 83: 7391–7394
Dunn JM, Phillips RA, Zhu X, Becker A, Gallie BL (1989) Mutations in the RBI gene and their effects on transcription. Mol Cell Biol 9: 4596–4604
Fearon E, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759–767
Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75: 1027–1038
Fishel R, Ewel A, Lee S, Lescoe MK, Griffith J (1994) Binding of mismatched microsatellite DNA sequences by the human msh2 protein. Science 266: 1403–1405
Francke U (1976) Retinoblastoma and chromosome 13. Cytogenet Cell Genet 16: 131–134
Friend S (1994) p53: a glimpse at the puppet behind the shadow play. Science 265: 334–335
Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643–646
Fuller GN, Bigner SH (1992) Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutat Res 276: 299–306
Fung YK, Murphree AL, T’Ang A, Qian J, Hinrichs SH, Benedict WF (1987) Structural evidence for the authenticity of the human retinoblastoma gene. Science 236: 1657–1661
Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M (1983) The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 11: 6883–6894
Gardiner-Garden M, Frommer M (1987) CpG islands in vertebrate genomes. J Mol Biol 196: 261–282
Garte SJ (1993) The c-myc oncogene in tumor progression. Crit Rev Oncog 4: 435–449
Goddard AD, Balakier H, Canton M, Dunn J, Squire J, Reyes E, Becker A, Phillips RA, Gallie BL (1988) Infrequent genomic rearrangement and normal expression of the putative RB1 gene in retinoblastoma tumors. Mol Cell Biol 8: 2082–2088
Goelz S, Vogelstein B, Hamilton S, Feinberg A (1985) Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228: 187–190
Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855–4878
Griesser H (1993) Applied molecular genetics in the diagnosis of malignant non-Hodgkin’s lymphoma. Diagn Mol Pathol 2: 177–191
Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M et al (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589–600
Harris H (1988) The analysis of malignancy in cell fusion: the position in 1988. Cancer Res 48: 3302–3306
Heisterkamp N, Stephenson JR, Groffen J, Hansen PF, De Klein A, Bartram CR, Grosveld G (1983) Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 306: 239–242
Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an anti-oxidant pathway to prevent apoptosis. Cell 75: 241–251
Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363: 558–561
Jen J, Powell SM, Papadopoulos N, Smith KJ, Hamilton SR, Vogelstein B, Kinzler KW (1994) Molecular determinants of dysplasia in colorectal lesions. Cancer Res 54: 5523–5526
Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262: 1274–1277
Katabuchi H, Lambers A, Ronnett BR, Leach FS, Cho KR, Hedrick L (1995) Mutations in the known mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas Cancer Res 55: 5556–5560
Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT (1993) Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 53: 5535–5541
Kim YI, Giuliano A, Hatch KD, Schneider A, Nour MA, Dallal GE, Selhub J, Mason JB (1994) Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma. Cancer 74: 893–899
Knudson A (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 68: 820–823
Knudson A (1985) Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45: 1437–1443
Konopka JB, Watanabe SM, Witte ON (1984) An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37: 1035–1042
Krontiris TG, Cooper GM (1981) Transforming activity of human tumor DNAs. Proc Natl Acad Sci USA 78: 1181–1184
Laird PW, Jaenisch R (1994) DNA methylation and cancer. Hum Mol Genet 3: 1487–1495
Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystrom-Lahti M, Guan X-Y, Zhang J, Meltzer PS, Yu J-W, Kao F-T, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin J-P, Jarvinen H, Petersen GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trent JM, de la Chapelle A, Kinzler K, Vogelstein B (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215–1226
Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY (1987) Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235: 1394–1399
Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Isaacs WB, Nelson WG (1994) Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 91: 11733–11737
Lindblom A, Tannergard P, Werelius B, Nordenskjold M (1993) Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nature Genet 5: 279–282
Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD (1983) Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306: 194–196
Liu B, Nicolaides NC, Markowitz S, Willson JKV, Parsons RE, Jen J, Peltomaki P, Delachapelle A, Hamilton SR, Kinzler KW (1995) Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet 9: 48–55
Loeb L (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51: 3075–3079
Lowy DR, Willumsen BM (1993) Function and regulation of ras. Annu Rev Biochem 62: 851–891
Lugo TG, Pendergast AM, Muller AJ, Witte ON (1990) Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247: 1079–1082
Makos M, Nelkin BD, Lerman MI, Latif F, Zbar B, Baylin SB (1992) Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci USA 89: 1929–1933
Makos N, Nelkin BD, Chazin VR, Cavenee WK, Brodeur GM, Baylin SB (1993a) DNA hypermethylation is associated with 17p allelic loss in neural tumors. Cancer Res 53: 2715–2718
Makos M, Nelkin BD, Reiter RE, Gnarra JR, Brooks J, Isaacs W, Linehan M, and Baylin SB (1993b) Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res 53: 2719–2722
McCormick F (1993) Signal transduction. How receptors turn Ras on. Nature 363: 15–16
Modrich P (1991) Mechanisms and biological effects of mismatch repair. Annu Rev Genet 25: 229–253
Nicolaides N, Papadopoulos N, Liu B, Vogelstein B, Kinzler K (1994) Mutations in two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371: 75–80
Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P, Markham A, Krush A, Petersen G, Hamilton S, Nilbert M, Levy D, Bryan T, Preisinger A, Smith K, Su L, Kinzler K, Vogelstein B (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665–669
Nystromlahti M, Sistonen P, Mecklin JP, Pylkkanen L, Aaltonen LA, Weissenbach J, Delachapelle A, Peltomaki P (1994) Close linkage to chromosome 3p and conservation of ancestral founding haplotype in hereditary nonpolyposis colorectal cancer families. Proc Natl Acad Sci USA 91: 6054–6058
Ocadiz R, Sauceda R, Cruz M, Graef AM, Ganglio P (1987) High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix. Cancer Res 47: 4173–4177
Ohtani-Fujita N, Fujita T, Aoike A, Osifchin NE, Robbins PD, Sakai T (1993) CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene 8: 1063–1067
Oshimura M, Kugoh H, Koi M, Shimizu M, Yamada H, Satoh H, Barrett JC (1990) Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines. J Cell Biochem 42: 135–142
Paik S (1992) Clinical significance of erbB-2 (HER-2/neu) protein. Cancer Invest 10: 575–579
Papadopoulos N, Nicolaides NC, Wei Y-F, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen GM, Watson P, Lynch HT, Peltomaki P, Mecklin J-P, de la Chapelle A, Kinzler KW, Vogelstein B (1994) Mutation of a mutL homolog in hereditary colon cancer. Science 263: 1625–1629
Parada LF, Tabin CJ, Shih C, Weinberg RA (1982) Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 297: 474–478
Parsons R, Li GM, Longley MJ, Fang WH, Papadopoulos N, Jen J, Delachapelle A, Kinzler KW, Vogelstein B, Modrich P (1993) Hypermutability and mismatch repair deficiency in RER+ tumour cells. Cell 75: 1227–1236
Parsons R, Li G-M, Longley M, Modrich P, Liu B, Berk T, Hamilton SR, Kinzler KW, Vogelstein B (1995) Mismatch repair deficiency in phenotypically normal human cells. Science 268: 738–740
Peltomaki P (1991) DNA methylation changes in human testicular cancer. Biochim Biophys Acta 1096: 187–196
Peltomaki P, Aaltonen L, Sistonen P, Pylkkanen L, Mecklin J, Jarvinen H, Green J, Jass J, Weber J, Leach F, Petersen G, Hamilton S, de la Chapelle A, Vogelstein B (1993a) Genetic mapping of a locus predisposing to human colorectal cancer. Science 260: 810–812
Peltomaki P, Lothe RA, Aaltonen LA, Pylkkanen L, Nystrom-Lahti M, Seruca R, David L, Holm R, Ryberg D, Haugen A, Brogger A, Borresen AL, de la Chapelle A (1993b) Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 53: 5853–5855
Pendergast AM, Müller AJ, Havlik MH, Maru Y, Witte ON (1991) BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell 66: 161–171
Perkins AS, Vande Woude GF (1993) Principles of molecular cell biology of cancer: oncogenes. In: Cancer: principles and practice of oncology. DeVita VT Jr, Hellman S, Rosenberg SA (eds) Lippincott, Philadelphia, pp 35–59
Perucho M, Goldfarb M, Shimizu K, Lama C, Fogh J, Wigler M (1981) Human-tumor-derived cell lines contain common and different transforming genes. Cell 27: 467–476
Potter MN, Cross NC, van Dongen JJ, Saglio G, Oakhill A, Bartram CR, Goldman JM (1993) Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review. Leukemia 7: 1302–1314
Powell SM, Zilz N, Beazerbarclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359: 235–237
Powell SM, Petersen GM, Krush AJ, Booker S, Jen J, Giardiello FM, Hamilton SR, Vogelstein B, Kinzler KW (1993) Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 329: 1982–1987
Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R et al (1993) Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res 53: 4960–4970
Pretlow TP, Brasitus TA, Fulton NC, Cheyer C, Kaplan EL (1993) K-ras mutations in putative preneoplastic lesions in human colon. J Natl Cancer Inst 85: 2004–2007
Rabbitts TH (1994) Chromosomal translocations in human cancer. Nature 372: 143–149
Rao PM, Antony A, Rajalakshmi S, Sarma DS (1989) Studies on hypomethylation of liver DNA during early stages of chemical carcinogenesis in rat liver. Carcinogenesis 10: 933–937
Rasheed BK, Bigner SH (1991) Genetic alterations in glioma and medulloblastoma. Cancer Metastasis Rev 10: 289–299
Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1–6
Rew DA (1994) Significance of aneuploidy. Br J Surg 81: 1416–1422
Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J (1993) Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 53: 1–4
Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM, Dryja TP (1991) Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 48: 880–888
Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Vecchio G, Matoskova B, Kraus MH, Difiore PP (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267: 381–383
Schwab M, Amler LC (1990) Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer. Genes Chrom Cancer 1: 181–193
Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ (1991) bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879–888
Shibata D, Almoguera C, Forrester K, Dunitz J, Martin SE, Cosgrove MM, Perucho M, Arnheim N (1990) Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas. Cancer Res 50: 1279–1283
Shih C, Weinberg RA (1982) Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell 29: 161–169
Shimizu M, Yokota J, Mori N, Shuin T, Shinoda M, Terada M, Oshimura M (1990) Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR. Oncogene 5: 185–194
Sidransky D, von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P et al (1991) Identification of p53 gene mutations in bladder cancers and urine samples. Science 252: 706–709
Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, Vogelstein B (1992) Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256: 102–105
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A et al (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707–712
Slebos RJ, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer CJ, Wagenaar SS, Vanderschueren RG, van Zandwijk N, Mooi WJ et al (1990) K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 323: 561–565
Sparkes RS, Murphree AL, Lingua RW, Sparkes MC, Field LL, Funderburk SJ, Benedict WF (1983) Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to esterase D. Science 219: 971–973
Strand M, Prolla TA, Liskay RM, Petes TD (1993) Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 365: 274–276
Strasser A, Harris AW, Cory S (1991) bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67: 889–899
Sved J, Bird A (1990) The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model. Proc Natl Acad Sci USA 87: 4692–4696
Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260: 816–819
Trent JM, Stanbridge EJ, McBride HL, Meese EU, Casey G, Araujo DE, Witkowski CM, Nagle RB (1990) Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 247: 568–571
Tsujimoto Y, Cossman J, Jaffe E, Croce CM (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440–1443
Urban T, Ricci S, Grange JD, Lacave R, Boudghene F, Breittmayer F, Languille O, Roland J, Bernaudin JF (1993) Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J Natl Cancer Inst 85: 2008–2012
Vaux DL, Cory S, Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440–442
Vogelstein B, Kinzler KW (1992) p53 function and dysfunction. Cell 70: 523–526
Vogelstein B, Fearon E, Hamilton S, Kern S, Preisinger A, Leppert M, Nakamura Y, White R, Smits A, Bos J (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525–532
Weinberg RA (1994) Oncogenes and tumor suppressor genes. Ca Cancer J Clin 44: 160–170
Weissman BE, Saxon PJ, Pasquale SR, Jones GR, Geiser AG, Stanbridge EJ (1987) Introduction of a normal human chromosome 11 into a Wilms’ tumor cell line controls its tumorigenic expression. Science 236: 175–180
Yandell DW, Campbell TA, Dayton SH, Petersen R, Walton D, Little JB, McConkie-Rosell A, Buckley EG, Dryja TP (1989) Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. N Engl J Med 321: 1689–1695
Yeivin A, Razin A (1993) DNA methylation: molecular biology and biological significance Birkhauser, Basel
Yen RW, Vertino PM, Nelkin BD, Yu JJ, el-Deiry W, Cumaraswamy A, Lennon GG, Trask BJ, Celano P, Baylin SB (1992) Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res 20: 2287–2291
Yunis JJ, Tanzer J (1993) Molecular mechanisms of hematologic malignancies. Crit Rev Oncog 4: 161–190
Zhou DJ, Gonzalez-Cadavid N, Ahuja H, Battifora H, Moore GE, Cline MJ (1988) A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinomas. Cancer 62: 1573–1576
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cho, K.R., Hedrick, L. (1997). Genetic Alterations in Human Tumors. In: Kastan, M.B. (eds) Genetic Instability and Tumorigenesis. Current Topics in Microbiology and Immunology, vol 221. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60505-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-60505-5_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64434-4
Online ISBN: 978-3-642-60505-5
eBook Packages: Springer Book Archive